YPrime’s Glucometer/eCOA Integration

Managing blood glucose levels is a critical component of many clinical studies, placing a significant burden on patients required to test and meticulously record their results. By listening closely to patients living with diabetes, YPrime leveraged key patient insights to develop an innovative glucometer functionality that improves the patient experience across any indication requiring blood glucose capture, unlocking new possibilities for endocrinology trials, autoimmune trials, and more. 

YPrime’s glucometer functionality offers a comprehensive set of features that address the unique needs of clinical trial participants and sponsors alike and delivers:  

Effortless Pairing — Glucometer devices effortlessly pair with YPrime’s patient-facing eCOA app, enabling connected secure data transfer—easing participant burden.  

Intelligent Categorization — Patients can easily categorize glucose readings, such as fasting or post-meal, while continuous data monitoring provides valuable context for clinical trial data analysis. 

Timely Alerts — High and low blood glucose alerts ensure timely notifications that promote symptom reporting, enhancing patient compliance.

Patient-Centric Design — Developed with extensive patient input, the glucometer feature offers an intuitive interface and seamless user experience.  

This release supports a wide selection of glucometer devices, expanding YPrime’s eCOA connected device integrations. The new glucometer functionality addresses the unique needs of diabetes patients, sites, and clinical trial sponsors alike.

Want to learn more about how YPrime’s glucometer functionality can elevate your clinical trials? Download our fact sheet today.